Domestic POCT Industry Leader
Guangzhou Wondfo Biotech Co., Ltd., headquartered in Guangzhou science city, has been focusing on the R&D, production, sales and service of point-of-care testing (POCT) products and providing customers with professional rapid diagnosis and chronic disease management solutions since founded in 1992.

Wondfo now has more than 3000 employees and a wide range of products for the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, and so on, widely sold to 140+ countries and regions.
Domestic POCT Industry Leader
Domestic POCT Industry Leader
Sound Product System
Continuous innovation drives us forward. Wondfo has developed “Night Technology Platforms”- the immune colloidal gold, immune-fluorescence, electrochemistry, dry biochemistry, chemiluminescence, molecular diagnostics, instrument, pathology, and biological raw material.
 
 
Based on the above technology platforms, Wondfo has extended the product lines to the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, etc. Our products are widely used in the rapid diagnosis and effective treatment monitoring of critical and severe diseases, chronic disease management, maternal and children healthcare, blood glucose monitoring, drug detection, alcohol testing, forensic expertise and other fields.

The Flu Series is the star product of Wondfo which keeps brilliant records. It is the only product in China obtaining the registration certificate for antigen detection of H7 subtype avian influenza virus. And it is the only influenza detection product in China with a full range of test menu (H7, FIuA, FIuB, FIuA&B).

In recent year